It’s a problem with not nearly enough attention. Prostate cancer hits men hard all over the world—it’s one of the biggest ...

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

Identifying and classifying gene mutations—which are the permanent changes in a person's DNA genetic code—are critical in better understanding, and with research, eventually treating or preventing, ...

Please provide your email address to receive an email when new articles are posted on . Black men with prostate cancer had significantly greater odds of having alterations in immunotherapy targets ...

Decision making is evidence based and must be shielded from lobbying The NHS draft recommendation against routine prostate ...

A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate cancer ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs that are initially effective lose their potency over time, as malignant ...

“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...

A new combination of drugs could help delay the advancement of a deadly form of prostate cancer in those with an advanced form of the disease, new research has found. The “striking” findings showed an ...

A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new ...